Stay informed with the latest litigation news. Explore now

Janssen Sciences Ireland Uc competitive analysis

Latest publications and patents of Janssen Sciences Ireland Uc New

Explore the latest publications and patents granted to Janssen Sciences Ireland Uc, showcasing their recent innovations and technological advancements.

Last updated on: Sep 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Janssen Sciences Ireland Uc

Jan 24, 2018Aqueous Suspensions Of Tmc278Opposition Rejected
Jul 12, 2017Pseudopolymorphic Forms Of A Hiv Protease InhibitorOpposition Rejected

Explore patent oppositions filed by Janssen Sciences Ireland Uc against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)PathwayDANA FARBER CANCER INSTITUTESep 13, 2018

Explore Janssen Sciences Ireland Uc's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 24, 2018Aqueous Suspensions Of Tmc2781
Jul 12, 2017Pseudopolymorphic Forms Of A Hiv Protease Inhibitor1

Latest PTAB cases involving Janssen Sciences Ireland Uc New

Discover the latest PTAB cases involving Janssen Sciences Ireland Uc, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 1, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Janssen Sciences Ireland Uc

IPR2015-01030Apr 9, 2015LUPINJANSSEN SCIENCES IRELAND UCInstitution Denied

Top competitors of Janssen Sciences Ireland Uc

Top competitors of Janssen Sciences Ireland Uc based on patent oppositions.